Califf Appears To Set 2025 As End Of His Term As US FDA Commissioner

Outlining what changes he wants to see at the agency before he leaves, Califf also worries congressional inaction on the user fee reauthorization could affect hiring efforts.

Robert Califf at Alliance for a Stronger FDA
FDA Commissioner Robert Califf spoke about a number of subjects during a Q&A session with the Alliance for a Stronger FDA. • Source: Screenshot

Robert Califf does not appear to be planning on running the US Food and Drug Administration after President Biden’s term ends.

Califf spoke about his vision for the agency during an Alliance for a Stronger FDA event, indicating that he hoped...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA

More from Agency Leadership